6:08 AM ET
8-K
Capital Raise
Regen BioPharma Capital Raise
Regen Biopharma entered into a $10 million equity line of credit with Coventry Enterprises, allowing the company to sell shares of common stock at a 20% discount to market prices over a 36-month term. Additionally, the company issued a $125,000 10% unsecured promissory note to Coventry, using a portion of the proceeds to satisfy $71,557 in existing convertible debt.
- Counterparty
- Coventry Enterprises, LLC
- Term
- 36 months